5.3. summary evidence guidelines diagnosis staging penile cancer. summary evidencelefor distinguishing t1 t2 disease, mri outperform clinical staging.2bfor predicting corporal invasion (t3 disease), mri showed pooled sensitivity 80% (95% ci: 70–87%) 96% (95% ci: 85–99%), respectively.2bmagnetic resonance imaging without artificial erection showed similar accuracy local staging.2bcomputed tomography, pet/ct mri imaging cannot detect micro-metastases therefore limited value clinically node-negative patients aim identify small sub-clinical ln metastasis.2ainguinal us + fnac sonographically abnormal nodes reduce need dsnb tumour positive, allowing earlier therapeutic treatment node-positive disease.2afor surgical staging cn0 patients, dsnb shown high diagnostic accuracy.2asentinel node biopsy shown lower complication rates compared modified-, superficial-, video-endoscopic inguinal lnd.2bimaging 18fdg-pet/ct clinically node-positive patients showed higher sensitivity/specificity ct alone pre-operative staging pelvic lns distant metastasis.2b recommendationsstrength ratingprimary tumourperform detailed physical examination penis external genitalia, recording morphology, size location penile lesion, including extent invasion penile (adjacent) structures.strongperform magnetic resonance imaging (mri) penis/primary tumour (artificial erection mandatory) uncertainty regarding corporal invasion and/or feasibility (organ-sparing) surgery. mri available, offer ultrasound (us) alternative option.weakobtain pre-treatment biopsy primary lesion malignancy clinically obvious, non-surgical treatment primary lesion planned (e.g., topical agents, laser, radiotherapy).stronginguinal lymph nodes (ln)perform physical examination groins. record number, laterality characteristics palpable/suspicious inguinal nodes.strongclinically node-negative (cn0)if palpable/suspicious nodes (cn0) physical examination, offer surgical ln staging patients high risk micro-metastatic disease (t1b higher).strongin case t1a g2 disease, also discuss surveillance alternative surgical staging patients willing comply strict follow-up.weakwhen surgical staging indicated, offer dynamic sentinel node biopsy (dsnb). dsnb available referral feasible, preferred patient well informed, offer inguinal lymph node dissection (ilnd) (open video-endoscopic).strongif dsnb planned, perform inguinal us first, fine needle aspiration cytology (fnac) sonographically abnormal lns.strongclinically node-positive (cn+)if palpable/suspicious node physical examination (cn+), obtain (image-guided) biopsy confirm nodal metastasis initiating treatment.strongin cn+ patients, stage pelvis exclude distant metastases 18f-fluoro-2-deoxy-d-glucose positron emission tomography (18fdg-pet) computed tomography (ct) ct chest abdomen initiating treatment.strong